ARTICLE | Company News
Aegis Therapeutics, Zelos deal
April 21, 2008 7:00 AM UTC
Zelos will use Aegis' Intravail permeation enhancer technology to develop an intranasal version of ZT-031 to treat osteoporosis and other bone diseases. Zelos' ZT-031 is a cyclic parathyroid hormon...